selected publications
-
Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma.
Liver cancer.
2015
Academic Article
GET IT
Times cited: 17 -
Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin.
Journal of acquired immune deficiency syndromes (1999).
2011
Academic Article
GET IT
Times cited: 10 - Smoking and hepatocellular carcinoma mortality. Experimental and therapeutic medicine. 2011 Academic Article GET IT
-
Obesity and microvascular invasion in hepatocellular carcinoma.
Cancer investigation.
2010
Academic Article
GET IT
Times cited: 27